drugs Class II Updated 2013-07-17

Lowlite Investments, Inc. D/B/A Olympia Pharmacy recalls Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pha

Recalled Product

Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Hazard / Issue

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: B3727 Exp 12/27/13, C5511 Exp 9/5/13, and L5312 Exp 11/30/13
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →

Related drugs Recalls

Noven Pharmaceuticals, Inc. recalls Daytrana (methylphenidate) transdermal system patch, Deliver

2012-06-20 · Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

Ben Venue Laboratories Inc recalls Midazolam HCl Injection, 5 mg/mL, 1 mL single use vials, pac

2012-06-20 · Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.

Noven Pharmaceuticals, Inc. recalls Daytrana (methylphenidate) transdermal system patch, Deliver

2012-06-20 · Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.

Noven Pharmaceuticals, Inc. recalls Daytrana (methylphenidate) transdermal system patch, Deliver

2012-06-20 · Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.